Quick Answer
Artiva Biotherapeutics, Inc. reported Total Revenue of $251.0 thousand for the year ending 2024.
- Artiva Biotherapeutics, Inc. showed a decrease of -99.3% in Total Revenue from 2023 to 2024.
- This data is from Artiva Biotherapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2025.
- XBRL data for this metric is available from 2023 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2023: $3.50 million | Q2 2023: $3.50 million | Q3 2023: $26.66 million | Q3 2023: $26.66 million.
- Over the full 3 years of available data (2023 to 2024), Artiva Biotherapeutics, Inc.'s Total Revenue has declined by 99.2%.
- Historical annual values: Fiscal year 2024: $251.0 thousand | Fiscal year 2023: $33.49 million | Fiscal year 2023: $32.92 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: